DISTRIBUTION OF LIPIDS IN 8,500 MEN WITH CORONARY-ARTERY DISEASE

被引:171
作者
RUBINS, HB
ROBINS, SJ
COLLINS, D
IRANMANESH, A
WILT, TJ
MANN, D
MAYOSMITH, M
FAAS, FH
ELAM, MB
RUTAN, GH
ANDERSON, JW
KASHYAP, ML
SCHECTMAN, G
机构
[1] VET AFFAIRS MED CTR, DEPT MED, MINNEAPOLIS, MN 55417 USA
[2] UNIV MINNESOTA, SCH MED, MINNEAPOLIS, MN 55455 USA
[3] VET ADM MED CTR, DEPT MED, BOSTON, MA USA
[4] VET ADM MED CTR, LIPID METAB SECT, BOSTON, MA USA
[5] BOSTON UNIV, SCH MED, BOSTON, MA 02118 USA
[6] VET ADM MED CTR, CTR VET AFFAIRS COOPERAT STUDIES COORDINATING, West Haven, CT 06516 USA
关键词
D O I
10.1016/S0002-9149(99)80761-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the present study we measured fasting lipid profiles in over 8,500 community-living men with coronary artery disease (CAD) to determine the distribution of lipid abnormalities in this population: 81% were white and 16% black,; mean age 62.9 +/- 8 years; mean total cholesterol 214 +/- 41 mg/dl; low-density lipoprotein (LDL) cholesterol 140 +/- 37 mg/dl; high-density lipoprotein (HDL) cholesterol 39 +/- 11 mg/dl; and triglycerides 190 +/- 142 mg/dl. After adjusting for age, the only significant difference between blacks and whites was a higher HDL cholesterol in blacks (45 vs 38 mg/dl, p <0.003). With use of cut points established by the National Cholesterol Education Program, 87% of subjects had high LDL cholesterol (greater than or equal to 100 mg/dl), 38% had HDL cholesterol (<35 mg/dl), and 33% had high triglycerides (>200 mg/dl). We estimated that 42% of men with CAD would be definite candidates for cholesterol-lowering medication according to the National Cholesterol Education Program guidelines and that 41% of those in whom cholesterol-lowering medication would not be definitely indicated had low levels of HDL cholesterol. We conclude that (1) black men with CAD have substantially higher HDL cholesterol than white men, (2) almost 90% of male patients with CAD are candidates for dietary intervention and >40% may need medications to lower LDL cholesterol, and (3) 40% of patients without a definite indication for cholesterol-lowering medications have low levels of HDL cholesterol.
引用
收藏
页码:1196 / 1201
页数:6
相关论文
共 30 条
[1]  
AGMON J, 1992, CIRCULATION, V86, P839
[2]   PLASMA-LIPID, LIPOPROTEIN CHOLESTEROL, AND APOPROTEIN DISTRIBUTIONS IN SELECTED UNITED-STATES COMMUNITIES - THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY [J].
BROWN, SA ;
HUTCHINSON, R ;
MORRISETT, J ;
BOERWINKLE, E ;
DAVIS, CE ;
GOTTO, AM ;
PATSCH, W .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (08) :1139-1158
[3]   DECREASED HDL2 AND HDL3 CHOLESTEROL, APO A-I AND APO A-II, AND INCREASED RISK OF MYOCARDIAL-INFARCTION [J].
BURING, JE ;
OCONNOR, GT ;
GOLDHABER, SZ ;
ROSNER, B ;
HERBERT, PN ;
BLUM, CB ;
BRESLOW, JL ;
HENNEKENS, CH .
CIRCULATION, 1992, 85 (01) :22-29
[4]   LIPOPROTEIN LIPIDS IN OLDER-PEOPLE - RESULTS FROM THE CARDIOVASCULAR HEALTH STUDY [J].
ETTINGER, WH ;
WAHL, PW ;
KULLER, LH ;
BUSH, TL ;
TRACY, RP ;
MANOLIO, TA ;
BORHANI, NO ;
WONG, ND ;
OLEARY, DH ;
FURBERG, CD ;
BOND, ME ;
HEISS, G ;
KLOPFENSTEIN, S ;
LYLES, M ;
MITTELMARK, M ;
TELL, GS ;
TOOLE, JF ;
CODY, M ;
GARNER, G ;
CRUISE, G ;
ROBBINS, J ;
BOMMER, W ;
LEE, M ;
SCHENKER, MB ;
TUPPER, CJ ;
HIMMELMANN, T ;
LABAW, F ;
KAY, J ;
BORHANI, P ;
FRIED, LP ;
COMSTOCK, GW ;
GERMAN, PS ;
KITTNER, SJ ;
KUMANYIKA, S ;
PRICE, TR ;
ROCK, RC ;
BRYAN, RN ;
SZKLO, M ;
TABATZNIK, B ;
TOCKMAN, MS ;
HILL, J ;
CHABOT, JB ;
CAULEY, J ;
MATTHEWS, K ;
NEWMAN, A ;
ORCHARD, TJ ;
RUTAN, GH ;
SCHULZ, R ;
SMITH, VE ;
WOLFSON, SK .
CIRCULATION, 1992, 86 (03) :858-869
[5]  
FRANK CW, 1970, ATHEROSCLEROSIS, P393
[6]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[7]   SERUM-LIPIDS AND LIPOPROTEINS AFTER MYOCARDIAL-INFARCTION - ASSOCIATIONS WITH CARDIOVASCULAR MORTALITY AND EXPERIENCE IN THE ASPIRIN-MYOCARDIAL-INFARCTION-STUDY [J].
FROST, PH ;
VERTER, J ;
MILLER, D .
AMERICAN HEART JOURNAL, 1987, 113 (06) :1356-1364
[8]   PREVALENCE OF RISK-FACTORS IN MEN WITH PREMATURE CORONARY-ARTERY DISEASE [J].
GENEST, JJ ;
MCNAMARA, JR ;
SALEM, DN ;
SCHAEFER, EJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (15) :1185-1189
[9]   FREQUENCY OF LOW SERUM HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS IN HOSPITALIZED-PATIENTS WITH DESIRABLE TOTAL CHOLESTEROL LEVELS [J].
GINSBURG, GS ;
SAFRAN, C ;
PASTERNAK, RC .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (02) :187-192
[10]   RATIONALE AND DESIGN OF A SECONDARY PREVENTION TRIAL OF INCREASING SERUM HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND REDUCING TRIGLYCERIDES IN PATIENTS WITH CLINICALLY MANIFEST ATHEROSCLEROTIC HEART-DISEASE (THE BEZAFIBRATE INFARCTION PREVENTION TRIAL) [J].
GOLDBOURT, U ;
BEHAR, S ;
REICHERREISS, H ;
AGMON, J ;
KAPLINSKY, E ;
GRAFF, E ;
KISHON, Y ;
CASPI, A ;
WEISBORT, J ;
MANDELZWEIG, L ;
ABINADER, E ;
AHARON, L ;
BRAUN, S ;
DAVID, D ;
FLICH, M ;
FRIEDMAN, Y ;
KRISTAL, N ;
LEIL, N ;
MARKIEWICZ, W ;
MARMOR, A ;
PALANT, A ;
PELLED, B ;
RABINOWITZ, B ;
REISIN, L ;
ROGUIN, N ;
ROSENFELD, T ;
SCHLESINGER, Z ;
SCLAROVSKY, S ;
SHERF, L ;
TZIVONI, D ;
ZAHAVI, I ;
ZION, M ;
BRUNNER, D ;
FRIDENSOHN, A ;
JAFARI, J ;
OSTFELD, B ;
ROCHFLEISH, S ;
SCHNEIDER, H ;
KHALID, S ;
NARINSKY, R ;
ROTZAK, R ;
VITRAI, J ;
PELLED, B ;
PARDU, J ;
LANIADO, S ;
ESHCHAR, Y ;
ARDITI, A ;
BOTWIN, S ;
ROGUIN, N ;
YAHALOM, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (11) :909-915